Pamela Wedel
Profile
Pamela Wedel worked as a Senior Vice President-Clinical Operations at Amplyx Pharmaceuticals, Inc. and as a Vice President-Development Operations at Spruce Biosciences, Inc. She obtained an undergraduate degree from San Diego State University.
Former positions of Pamela Wedel
| Companies | Position | End |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Chief Operating Officer | - |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | - |
Training of Pamela Wedel
| San Diego State University | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Pamela Wedel